Skip to main content
. 2009 Jan 19;2(3-4):101–125. doi: 10.1007/s12079-008-0035-1
Treatments Hypertrophy Markers(% of control) Apoptosis Markers (% of control)
Total protein/cell No. ANP mRNA α-sk actin mRNA Caspase 3/7 Activity Viable cell number
rhCTGF (500 ng/mL) 183 ± 22* 145 ± 16* 129 ± 10* 179 ± 12* 79 ± 8*
Glucose (30 mM) 148 ± 24* 340 ± 43* 201 ± 27* 228 ± 5.0* 79 ± 2*
Palmitate (50 μM) 165 ± 29* 161 ± 23* 155 ± 18* 192 ± 19* 68 ± 5*
Palmitate (100 μM) 397 ± 7.0* 143 ± 24 189 ± 39* 262 ± 49* 53 ± 5*
Glucose (30 mM) + CTGF SiRNA 114 ± 16+ ND ND 156.3 ± 17+ 88 ± 8+
Palmitate (50 μM) + CTGF SiRNA 107 ± 1.8+ ND ND 123.5 ± 35+ 98 ± 7+